Our kind sponsors and partners:
DNB is Norway's largest financial services group and one of the largest in the Nordic region in terms of market capitalization. The Group offers a full range of financial services, including loans, savings, advisory services, insurance and pension products for retail and corporate customers. Within DNB’s international strategy, healthcare is a prioritized area.
DNB is the Nordic Healthcare Bank and a top ranking healthcare bank in the US. The clients are serviced by bankers and industry experts located in New York, Oslo and Stockholm. The company assists international pharma clients with business development by actively monitoring the Nordic early-stage companies for promising technologies/products
Precision for Medicine, Oncology and Rare Disease is the first comprehensive, fully integrated CRO devoted to oncology and rare disease combining this unique experience with Omics, big data + biomarker-guided drug development.
Precision’s uniquely integrated offering enables the science of precision medicine by combining novel clinical trial designs, industry-leading operational and medical experts, advanced biomarker solutions, and an unequivocal passion for rare diseases and oncology. We provide an uncommon array of talent and services to enable our pharmaceutical and life sciences clients to access new advancements, stay ahead of regulatory changes and ultimately achieve their goals faster. The result: a tailored pathway to approval for oncology and rare disease innovators.